Member Info for martinu

I would be interested to know how this is progressing, if it still is. From HY accounts.

"More recently, we have been able to capitalise on the huge public and media interest in injectable weight loss GLP-1 agonists like Semaglutide, marketed as Ozempic and Wegovy. Whilst SlimBiome® and the GLP-1 agonists both regulate insulin response and slow down stomach emptying improving appetite control, SlimBiome® works in a totally natural, non-invasive way and without any adverse side effects. Recent work with dieticians at a specialist London obesity clinic indicates that SlimBiome® may also have potential as an adjunct to treatment with Ozempic/Wegovy. Work is ongoing to explore whether combining SlimBiome® with these drugs may help to reduce drug dosage, and thereby the cost of treatment and side effects, and enhance or prolong the appetite suppressant effect of the drugs. "

Mol , a very detailed and helpful run through of possible 24 revenues. Let's hope the outturn is closer to your estimate. But given what SOH has said, as I mentioned below, it is possible Morepen and/or Nouri orders may not have been in time for 24 accounts.

Bk, as good as any. 😊 Booked revenue is apparently difficult to judge, as it appears that the gap between sales (esp first orders) and booked revenue can be very lengthy. By this stage in the business you might have expected the lumpiness to have flattened out. But ...

Meet the team!

https://www.linkedin.com/company/probiotix-health

Perhaps they could pre announce a results date, like last year. Then if they are to be later this year, we would all know.

Well as long as he brings in more than he costs. Perhaps Zach S can give him some tips.

Morepen does appear to be going well on Amazon India. And the support the app is a great idea. Perhaps Morepen and Opti could work together in other regions. A bit like AS was alluding to.

TW , why are you expecting a general trading update? It's not a regular occurrence at this time, is it?

Mol, thanks. Over 600 companies and we are one of eight to be mentioned by name. A feather in the Opti cap.

Mol, thanks. Article says Nouri reckon they have USA exclusivity on the SlimBiome blend. Would that be a surprise?

Just for fun or perhaps to be mischievous, I searched Croda RNS for "acquisition/s". It appears 46 times!

Thanks for extracts. The last quote is interesting.

I'm annoyed shares on Aquis. So is that creating a false SP?

Possibly so but SP has risen quite a lot recently, so I suppose could have been worse? If they take up the options at say, 19p I won't be complaining too much as initial offering was at 21p. Though could argue they allowed SP to fall by very poor news flow.

I think Steen reckoned he could make £10m annual revenue in time. Let's see.

He definitely has some trust to recover after the sale of 23% of company to associate Fred B.

Hope so. It was the jewel in the Opti crown.

"ProBiotix has entered into a material and exclusive long-term partnership agreement with Kemin China Technology Co. Ltd ("KCG"). The deal will allow KCG to sell the Company's proprietary probiotic strain LPLDL®, as a cardiometabolic health supplement ingredient in China, Hong Kong and Macau, with the opportunity to discuss expansion into other regions, driven by Kemin's global commercial operations. ProBiotix will supply its raw materials in bulk to KCG, whereupon LPLDL® will be marketed and sold under a co-branding arrangement. With the Far East being a significant market opportunity for ProBiotix, we will continue to retain the rights to sell finished formats under our own brand or as private label in China."

Sounds promising, if all goes well. Revenues building. But goodness knows how the MMs are pricing the share!

Good to see a f/C of tonnes. SOH has said recently he often halves f/C to be prudent. Good announcement and hopefully more to come. Just one proviso: we need to keep hold of the partnership (s) for longer than a year. In the past we seem to have lost as many as we have gained. Hence no real accumulation of revenues. RNS says more products to come depending on sales. Let's hope so.

Keep 'em rolling Stevie O' 😊👍

Given the more recent announcement (unofficial?, can't remember if source was RNS or other) of testing of SweetBiotix in tea and coffee, it suggests to me there has been at least a partial change of tack. Quicker to market? Couldn't be any slower!!!

Mol, and that £1.3m now worth getting on for treble that.

morepen have a new marketing manager.

https://www.linkedin.com/mwlite/profile/in/e****a-goswami-422a251a?trk=organization_guest_main-feed-card-text